165 related articles for article (PubMed ID: 2431729)
1. Studies on B lymphoid tumors treated with monoclonal anti-idiotype antibodies: correlation with clinical responses.
Lowder JN; Meeker TC; Campbell M; Garcia CF; Gralow J; Miller RA; Warnke R; Levy R
Blood; 1987 Jan; 69(1):199-210. PubMed ID: 2431729
[TBL] [Abstract][Full Text] [Related]
2. Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies.
Meeker T; Lowder J; Cleary ML; Stewart S; Warnke R; Sklar J; Levy R
N Engl J Med; 1985 Jun; 312(26):1658-65. PubMed ID: 3923352
[TBL] [Abstract][Full Text] [Related]
3. Anti-idiotypic antibodies recognizing stable epitopes limit the emergence of idiotype variants in a murine B cell lymphoma.
Weiner GJ; Kaminski MS
J Immunol; 1990 Mar; 144(6):2436-45. PubMed ID: 1690244
[TBL] [Abstract][Full Text] [Related]
4. Molecules recognized by anti-idiotypic monoclonal antibodies to the B cell lymphoma, BCL1.
Tamura GS; McGrath MS; Weissman IL
J Mol Cell Immunol; 1987; 3(4):243-53. PubMed ID: 3509925
[TBL] [Abstract][Full Text] [Related]
5. The generation of monoclonal anti-idiotype antibodies to human B cell-derived leukemias and lymphomas.
Giardina SL; Schroff RW; Kipps TJ; Woodhouse CS; Abrams PG; Rager HC; Morgan AC; Foon KA
J Immunol; 1985 Jul; 135(1):653-8. PubMed ID: 3873497
[TBL] [Abstract][Full Text] [Related]
6. Treatment of lymphoid tumors with anti-idiotype antibodies.
Stevenson GT; Stevenson FK
Springer Semin Immunopathol; 1983; 6(1):99-115. PubMed ID: 6351310
[No Abstract] [Full Text] [Related]
7. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants.
Kaminski MS; Kitamura K; Maloney DG; Campbell MJ; Levy R
J Immunol; 1986 Feb; 136(3):1123-30. PubMed ID: 3484499
[TBL] [Abstract][Full Text] [Related]
8. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors.
Kwak LW; Campbell MJ; Czerwinski DK; Hart S; Miller RA; Levy R
N Engl J Med; 1992 Oct; 327(17):1209-15. PubMed ID: 1406793
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitro.
Maloney DG; Kaminski MS; Burowski D; Haimovich J; Levy R
Hybridoma; 1985; 4(3):191-209. PubMed ID: 3899906
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous alteration of idiotype in a monoclonal B-cell lymphoma. Escape from detection by anti-idiotype.
Raffeld M; Neckers L; Longo DL; Cossman J
N Engl J Med; 1985 Jun; 312(26):1653-8. PubMed ID: 3923351
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of myeloma cells by anti-idiotype antibodies in the absence of membrane-bound immunoglobulin.
Moshitzky S; Kukulansky T; Haimovich J; Hollander N
Immunol Cell Biol; 2008; 86(3):261-7. PubMed ID: 18195726
[TBL] [Abstract][Full Text] [Related]
12. The use of a monoclonal anti-idiotype antibody to study the biology of a human B cell lymphoma.
Hatzubai A; Maloney DG; Levy R
J Immunol; 1981 Jun; 126(6):2397-402. PubMed ID: 6785351
[TBL] [Abstract][Full Text] [Related]
13. Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon.
Brown SL; Miller RA; Horning SJ; Czerwinski D; Hart SM; McElderry R; Basham T; Warnke RA; Merigan TC; Levy R
Blood; 1989 Feb; 73(3):651-61. PubMed ID: 2465039
[TBL] [Abstract][Full Text] [Related]
14. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody.
Foon KA
N Engl J Med; 1982 Sep; 307(11):686-7. PubMed ID: 6981064
[No Abstract] [Full Text] [Related]
15. Monoclonal anti-light chain idiotype as a tumor-specific probe for human neoplastic B lymphocytes.
Wrightham M; Tutt AL; Glennie MJ; Hamblin TJ; Stevenson GT; Stevenson FK
Blood; 1987 Mar; 69(3):919-23. PubMed ID: 2434161
[TBL] [Abstract][Full Text] [Related]
16. Analysis with antiidiotype antibody of a patient with chronic lymphocytic leukemia and a large cell lymphoma (Richter's syndrome).
Bertoli LF; Kubagawa H; Borzillo GV; Mayumi M; Prchal JT; Kearney JF; Durant JR; Cooper MD
Blood; 1987 Jul; 70(1):45-50. PubMed ID: 3297206
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of a murine B cell tumor with antibodies and F(ab')2 fragments against idiotypic determinants of its cell surface IgM.
Perek Y; Hurwitz E; Burowski D; Haimovich J
J Immunol; 1983 Sep; 131(3):1600-3. PubMed ID: 6604103
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of a murine B cell lymphoma. Isolation and characterization of idiotypic variants.
Starnes CO; Carroll WL; Campbell MJ; Houston LL; Apell G; Levy R
J Immunol; 1988 Jul; 141(1):333-9. PubMed ID: 3132505
[TBL] [Abstract][Full Text] [Related]
19. Effects of anti-IgM on mitogen-induced proliferation of human B-lymphocyte malignancies.
Baeker TR; Rothstein TL
Clin Immunol Immunopathol; 1986 May; 39(2):285-97. PubMed ID: 3084144
[TBL] [Abstract][Full Text] [Related]
20. Idiotype variants emerging after anti-idiotype monoclonal antibody therapy of a murine B cell lymphoma.
Weiner GJ; Kaminski MS
J Immunol; 1989 Jan; 142(1):343-51. PubMed ID: 2783325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
